Our group recently demonstrated that the inhibition of Wee1 kinase, via AZD1775, significantly reduced cell viability in ACC models and that this effect was enhanced in the absence of FLNA, suggesting a potential interaction between cytoskeletal regulation and DNA damage checkpoint control [23]. The gene discussed is FLNA; the disease is adrenal cortex carcinoma.